APA (7th ed.) Citation

Schaumann, A., Jakob, W., Rosenstengel, C., Ringel, F., Tüttenberg, J., & Vajkoczy, P. (2016). COXIBRAIN: Results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients. Acta neurochirurgica, 158(11), . https://doi.org/10.1007/s00701-016-2949-3

Chicago Style (17th ed.) Citation

Schaumann, Andreas, Wibke Jakob, Christian Rosenstengel, F. Ringel, Jochen Tüttenberg, and Peter Vajkoczy. "COXIBRAIN: Results of the Prospective, Randomised, Phase II/III Study for the Selective COX-2 Inhibition in Chronic Subdural Haematoma Patients." Acta Neurochirurgica 158, no. 11 (2016). https://doi.org/10.1007/s00701-016-2949-3.

MLA (9th ed.) Citation

Schaumann, Andreas, et al. "COXIBRAIN: Results of the Prospective, Randomised, Phase II/III Study for the Selective COX-2 Inhibition in Chronic Subdural Haematoma Patients." Acta Neurochirurgica, vol. 158, no. 11, 2016, https://doi.org/10.1007/s00701-016-2949-3.